Alpha Teknova, Inc. (TKNO)Healthcare | Drug Manufacturers - Specialty & Generic | Hollister, United States | NasdaqGM
7.60 USD
-0.19
(-2.439%) ⇩
(Oct. 15, 2026, 4 p.m.
EDT)
After hours: 7.60 |
Hot Take ↕ | Oct. 10, 2026, 10:41 a.m. EDT
The investment case for Alpha Teknova is fundamentally broken by a severe multi-year structural decline. Over the last four years, the stock has lost nearly 80% of its value, driven by two consecutive years of double-digit declines that wiped out earlier gains. This trajectory is the market's verdict on the business quality, rendering any current valuation metrics like P/S or P/B misleading as they reflect a distressed asset rather than a growth opportunity. The company is burning cash with negative operating margins and free cash flow, and the balance sheet is fragile with debt exceeding cash reserves. While the CEO recently bought shares, this does not offset the reality that the core business is failing to generate sustainable returns. On the short end, the recent price action shows a slight rebound, but the options market remains heavily skewed toward downside protection, indicating that bulls are not yet convinced a reversal is imminent. Without a clear turnaround in profitability or a catalyst to arrest the multi-year slide, this remains a speculative hold with significant tail risk. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.311881 |
| AutoETS | 0.311885 |
| AutoTheta | 0.312293 |
| MSTL | 0.321526 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 3.57 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.527 |
| Excess Kurtosis | -0.52 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 43.783 |
| Revenue per Share | 0.816 |
| Market Cap | 408,030,688 |
| Forward P/E | -40.00 |
| Beta | 0.86 |
| Profit Margins | -38.37% |
| Website | https://www.teknova.com |
As of Oct. 10, 2026, 10:41 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume relative to calls, creating a distinct 'bear put' skew. While there is some call interest at the $7.50 strike, the overwhelming open interest in puts suggests a consensus expectation of further downside or a lack of confidence in a near-term recovery, despite the recent price bounce.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.48098862 |
| Address1 | 2,451 Bert Dr. |
| All Time High | 30.89 |
| All Time Low | 1.155 |
| Ask | 7.05 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 279,390 |
| Average Daily Volume3 Month | 235,525 |
| Average Volume | 235,525 |
| Average Volume10Days | 279,390 |
| Beta | 0.858 |
| Bid | 4.09 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | 1.166 |
| City | Hollister |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.6 |
| Current Ratio | 4.485 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 7.84 |
| Day Low | 7.32 |
| Debt To Equity | 43.783 |
| Display Name | Alpha Teknova |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,822,400 |
| Earnings Call Timestamp Start | 1,793,822,400 |
| Earnings Timestamp | 1,793,822,400 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | -8,973,000 |
| Ebitda Margins | -0.20533001 |
| Enterprise To Ebitda | -46.584 |
| Enterprise To Revenue | 9.565 |
| Enterprise Value | 418,002,656 |
| Eps Current Year | -0.24 |
| Eps Forward | -0.19 |
| Eps Trailing Twelve Months | -0.29 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.6797 |
| Fifty Day Average Change | -0.07969999 |
| Fifty Day Average Change Percent | -0.010378009 |
| Fifty Two Week Change Percent | 48.09886 |
| Fifty Two Week High | 9.48 |
| Fifty Two Week High Change | -1.8799996 |
| Fifty Two Week High Change Percent | -0.19831221 |
| Fifty Two Week Low | 1.91 |
| Fifty Two Week Low Change | 5.69 |
| Fifty Two Week Low Change Percent | 2.9790578 |
| Fifty Two Week Range | 1.91 - 9.48 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,624,627,800,000 |
| Float Shares | 10,990,521 |
| Forward Eps | -0.19 |
| Forward P E | -40.0 |
| Free Cashflow | -735,250 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 158 |
| Fullday Change | -0.19000006 |
| Fullday Change Percent | -2.4390252 |
| Fullday Price | 7.6 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.34597 |
| Gross Profits | 15,119,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09309 |
| Held Percent Institutions | 0.87351996 |
| Implied Shares Outstanding | 53,688,246 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-06-25 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California. |
| Long Name | Alpha Teknova, Inc. |
| Market | us_market |
| Market Cap | 408,030,688 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_116531601 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -16,769,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 479,436,036 |
| Number Of Analyst Opinions | 6 |
| Open | 7.58 |
| Operating Cashflow | -6,272,000 |
| Operating Margins | -0.23718001 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 831 637 1100 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 7.6 |
| Post Market Time | 1,792,094,495 |
| Previous Close | 7.79 |
| Price Eps Current Year | -31.666666 |
| Price Hint | 2 |
| Price To Book | 6.51801 |
| Price To Sales Trailing12 Months | 9.337087 |
| Profit Margins | -0.38373002 |
| Quick Ratio | 3.324 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | -0.19 |
| Regular Market Change Percent | -2.43902 |
| Regular Market Day High | 7.84 |
| Regular Market Day Low | 7.32 |
| Regular Market Day Range | 7.32 - 7.84 |
| Regular Market Open | 7.58 |
| Regular Market Previous Close | 7.79 |
| Regular Market Price | 7.6 |
| Regular Market Time | 1,792,094,400 |
| Regular Market Volume | 353,080 |
| Return On Assets | -0.09276 |
| Return On Equity | -0.24188 |
| Revenue Growth | 0.185 |
| Revenue Per Share | 0.816 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 53,688,246 |
| Shares Percent Shares Out | 0.0304 |
| Shares Short | 1,634,663 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,552,122 |
| Short Name | Alpha Teknova, Inc. |
| Short Percent Of Float | 0.1487 |
| Short Ratio | 6.66 |
| Source Interval | 15 |
| State | CA |
| Symbol | TKNO |
| Target High Price | 12.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 9.66667 |
| Target Median Price | 9.5 |
| Total Cash | 17,436,000 |
| Total Cash Per Share | 0.325 |
| Total Debt | 27,408,000 |
| Total Revenue | 43,700,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.29 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.7033 |
| Two Hundred Day Average Change | 2.8967 |
| Two Hundred Day Average Change Percent | 0.6158867 |
| Type Disp | Equity |
| Volume | 353,080 |
| Website | https://www.teknova.com |
| Zip | 95,023 |